Sign in
Not yet recruitingNo phase

Enhanced External Counter Pulsation on Afterload Mismatch Rate in Post-TEER (PAMPER)

Key facts

Who runs it
Sun Yat-sen University
Where
China6 sites in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
176 people, planned
Started
1 Mar 2024
Expected to end
31 Dec 2028
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • EECP
  • Sham-EECP
Record updated
5 February 2024

Who can take part

Age
18 years to 100 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (8)Hide the full registry criteria

Who can take part

  • Consent to participate
  • Age > 18 years
  • Moderate or severe Mitral Regurgitation
  • Patients who meet the indications for transcatheter Mitral valve edge-to-edge repair and have undergone TEERM

Who cannot take part

  • Lower extremity deep vein thrombosis, active thrombophlebitis
  • Moderate or severe aortic stenosis/insufficiency
  • Moderate pulmonary hypertension (mean pulmonary pressure >50mmHg)
  • Aortic aneurysm/cerebral aneurysm Uncontrolled hypertension (>180/110mmHg) Arrhythmias that may interfere with the ECG gating function of the EECP device Hemorrhagic disease or obvious bleeding tendency Limb infection Pregnant/lactating women

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Mitral regurgitation

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this multicenter, randomized, double-blind controlled study is to learn about the individuals after transcatheter edge-to-edge mitral valve repair (TEER). The main questions it aims to answer are: (1) can enhanced external counterpulsation (EECP) reduce the prevalence of afterload mismatch after TEER? (2) can EECP prevent the major adverse cardiac events after TEER? Participants will be randomly assigned into EECP or Sham-EECP intervention after TEER. Researchers will compare the EECP and Sham-EECP to see if it helps reduce the prevalence of afterload mismatch after TEER.

The 2 groups in the trial

  • EECP ArmTreatment being tested

    Participants would be assigned for treating with EECP initiated with 0.030 MPa, 30-45 minutes per day, 5 days per week, 7 weeks in total.

    Treatment: EECP

  • Sham-EECP ArmSham treatment, for comparison

    Participants would be assigned for treating with Sham-EECP initiated with 70 mmHg, 30-45 minutes per day, 5 days per week, 7 weeks in total.

    Treatment: Sham-EECP

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Enhanced External Counter Pulsation on Afterload Mismatch Rate in Post-TEER (PAMPER): A Multicenter, Randomized, Double-blind Controlled Study
Criteria questions
Built from NCT06227286, who can take part
Record updated
5 February 2024